Kratom and 7-OH can feel like ‘a miracle.’ They can also be addictive

by | Nov 16, 2026 | Health

Kratom and 7-OH can feel like 'a miracle.' They can also be addictive

Kratom and its concentrated derivative 7-OH have become increasingly available through retail channels including gas stations, smoke shops, and online vendors. These products are marketed in various forms including powders, tablets, gummies, and tonics. The compounds have attracted users seeking pain relief, mood enhancement, or alternatives to traditional opioids, with some estimating lifetime use at over 5 million Americans and others suggesting figures as high as 15 million.

However, regulatory and medical attention has intensified due to concerns about addiction and health risks. Poison control center data from 53 facilities documented a roughly 1,200% increase in calls related to kratom between 2015 and 2025. The same reporting period documented 233 deaths associated with kratom, though 79% of those involved multiple substances. A University of Virginia emergency medicine professor noted the findings were striking, though reports covered both traditional kratom and concentrated derivatives without distinguishing between them.

The federal government is moving toward restrictions on highly concentrated 7-OH products. In August, the Drug Enforcement Administration restricted three semi-synthetic opioids derived from related compounds by listing them under the Controlled Substances Act. Following advocacy group opposition and a Department of Health and Human Services recommendation in October, the DEA adjusted course to target products with higher concentrations specifically, while attempting to spare natural kratom products from restrictions. A new federal restriction on certain 7-OH products was set to potentially take effect on Nov. 13, 2026.

Opioid death statistics have shown mixed trends, with 2023 recording over 79,000 deaths and 2024 showing 54,000. Advocates for kratom and 7-OH products argue they provide pain management and mental health benefits while steering users away from prescription opioids. Opponents contend that concentrated derivatives, which may not be clearly labeled, carry significant addiction risks that users often underestimate.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI